Testing for viruses after a monkey bite

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study enrolls adults (≥18) who sustained WHO category 3 bites from nonhuman primates, including both recent and past exposures. Participants provide blood and saliva samples, with an optional genetic analysis component for those who consent. Samples will be tested for simian viruses (STLV-1 and SFV) to estimate prevalence and characterize possible transmission after bites. Enrollment and sample processing are conducted at the Institut Pasteur Medical Center in Paris.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* Bite inflicted by an HNP (WHO category 3 level)
* Written informed consent
* Affiliation with a social security scheme (excluding State Medical Aid

Specific criteria for genetic analyses:

* Participant has checked the boxes for participation in the genetic component.

Exclusion Criteria:

* Patient presenting only with scratches inflicted by a PNH
* Medical management incompatible with the objectives of the study
* Patient who, in the doctor's opinion, is unlikely to comply with the study protocol
* Health conditions are incompatible with the sample collection required by the study
* Patient under legal protection (guardianship or trusteeship)

Where it's running

• Institut Pasteur Medical Center
  Paris, France Recruiting

Study contacts

• Principal investigator: Patrick HOCHEDEZ, Dr — Institut Pasteur Medical Center
• Study coordinator: Florence BUSEYNE, PhD
• Email: florence.buseyne@pasteur.fr
• Phone: 0145688899

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• MOPEVAC-Las vaccine in healthy adults to test safety and immune response for Lassa fever

  A small study in healthy adults checks if MOPEVAC-Las is safe and can trigger an immune response, trying different dose levels.

  Recruiting Phase 1 Institut Pasteur · Paris · NCT07833436

• Speech therapy to improve lip-reading for people who use hearing aids

  This will see if speech therapy for lip-reading improves visual speech recognition in adults with moderate-to-severe hearing loss who wear hearing aids.

  Recruiting Institut Pasteur · Paris · NCT07028658

• How breast milk affects virus infectivity and transmission

  This project will test whether components of donated breast milk change how viruses such as HTLV-1, Zika, dengue, yellow fever, and tick-borne encephalitis infect cells and could affect transmission.

  Recruiting Institut Pasteur · Paris · NCT06738563

• Exploring immune responses to yellow fever vaccination

  This study is testing whether yellow fever and typhoid vaccines can boost the immune system's ability to fight off other infections, and it involves collecting blood samples from participants after they get vaccinated.

  Recruiting Institut Pasteur · Paris · NCT06718127

• Observing health issues faced by travelers

  This study is trying to find out how often travelers get sick when visiting emerging countries and what factors might increase their risk, so we can give better advice to help keep them healthy.

  Recruiting Institut Pasteur · Paris · NCT06701890

• Comparing yellow fever vaccination effects during and outside of pregnancy

  This study tests how well the yellow fever vaccine works and how safe it is for pregnant women compared to those who are not pregnant.

  Recruiting Institut Pasteur · Paris · NCT06694766

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.